Key Drivers
- Narrower Losses
- Strong Liquidity
- Negative Cash Flow
AIAI Summary
HTFL's shift to a coronary-intelligence platform led by Plaque Analysis offers meaningful upside, but its premium valuation already prices in successful reimbursement, adoption, and scaling; investors should wait for sustained declining free-cash-flow burn and proof of durable commercialization before adding exposure.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Narrower Losses
- •Strong Liquidity
- •Negative Cash Flow
HTFL's improving margins and narrowed loss are encouraging, but persistent cash burn, weak returns, declining equity, and high valuation multiples warrant caution.
Price Behavior
Key Price Behavior Insights:
- •Uptrend intact
- •Recent breakout
- •Support watch
HTFL's last-month uptrend and break above $50.00 are constructive, but holding above $50.75 is key while a drop below $48.30 risks a pullback toward $45.49.
Recent breakout above the $50.00–$50.43 ceiling
Sentiment & News
Key News Insights:
- •Institutional accumulation
- •Clinical validation
- •Insider selling
Institutional buying and strong FUSION trial results support Heartflow's outlook, though insider selling and competitive concerns warrant caution.
Overall sentiment is constructive, but elevated valuation and insider sales may increase near-term volatility
Similar Companies in Healthcare
Other companies in the same sector with AI ratings